Medpace Holdings, Inc. (MEDP)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Medpace Holdings, Inc. (MEDP)

Go deeper and ask any question about MEDP

Company Performance

Current Price

as of Sep 13, 2024

$351.67

P/E Ratio

33.06

Market Cap

$10.9B

Description

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Metrics

Overview

  • HQCincinnati, OH
  • SectorCommercial Services
  • IndustryMiscellaneous Commercial Services
  • TickerMEDP
  • Price$351.67+1.95%

Trading Information

  • Market Cap$10.90B
  • Float82.19%
  • Average Daily Volume (1m)264,489
  • Average Daily Volume (3m)282,051
  • EPS$11.02

Company

  • Revenue$2.03B
  • Rev Growth (1yr)14.59%
  • Net Income$88.35M
  • Gross Margin27.76%
  • EBITDA Margin21.28%
  • EBITDA$112.38M
  • EV$12.86B
  • EV/Revenue6.33
  • P/E33.06
  • P/S5.56